Kallebo Lisa Michelle has filed 5 insider transactions across 1 company since December 2024.
Most recent transaction: a grant/award of 62900 shares of ADC Therapeutics SA ($ADCT) on February 13, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | ADC Therapeutics SA | $ADCT | Kallebo Lisa Michelle | Chief Accounting Officer | A | Common Shares | 62900 | $3.99 | 133,657.0000 | 136,446,534 | 88.90% | 0.05% |
| Feb. 13, 2026 | ADC Therapeutics SA | $ADCT | Kallebo Lisa Michelle | Chief Accounting Officer | F | Common Shares | 5433 | $3.99 | 128,224.0000 | 136,446,534 | 4.06% | 0.00% |
| Dec. 6, 2025 | ADC Therapeutics SA | $ADCT | Kallebo Lisa Michelle | Chief Accounting Officer | F | Common Shares | 7140 | $3.29 | 70,757.0000 | 136,446,534 | 9.17% | 0.01% |
| Feb. 13, 2025 | ADC Therapeutics SA | $ADCT | Kallebo Lisa Michelle | Chief Accounting Officer | A | Common Shares | 41900 | $1.61 | 77,897.0000 | 97,159,966 | 116.40% | 0.04% |
| Dec. 6, 2024 | ADC Therapeutics SA | $ADCT | Kallebo Lisa Michelle | Chief Accounting Officer | F | Common Shares | 6503 | $3.13 | 35,997.0000 | 104,824,877 | 15.30% | 0.01% |